Aubrey Allen, DO
Payments from drug & device makers
Across 287 payments — averaging $56.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cornerstone Urology Network, LLC$7K
- Intuitive Surgical$3K
- Johnson & Johnson$941
- Medtronic$836
- Dendreon Pharmaceuticals LLC$502
- AbbVie$444
- plus $4K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cornerstone Urology Network, LLC | 1 | $7,000 |
| Intuitive Surgical | 1 | $3,000 |
| Johnson & Johnson(2 entities) | 41 | $941 |
| Medtronic | 35 | $836 |
| Dendreon Pharmaceuticals LLC | 18 | $502 |
| AbbVie(2 entities) | 28 | $444 |
| Astellas Pharma US Inc | 15 | $387 |
| Boston Scientific | 7 | $318 |
| Endo Pharmaceuticals Inc. | 14 | $314 |
| Sumitomo Pharma America, Inc. | 17 | $300 |
| Pfizer | 14 | $299 |
| Urogen Pharma, Inc. | 16 | $267 |
| Axonics, Inc. | 11 | $203 |
| Procept Biorobotics Corporation | 5 | $185 |
| Bayer | 9 | $179 |
| Myriad Genetic Laboratories, Inc. | 6 | $113 |
| Endo USA, Inc. | 5 | $112 |
| Olympus America Inc. | 2 | $97 |
| Urovant Sciences Inc | 5 | $95 |
| Novartis | 5 | $88 |
| Baxter Healthcare | 3 | $78 |
| Merck | 4 | $76 |
| Myovant Sciences Inc. | 5 | $72 |
| Tolmar, Inc. | 3 | $59 |
| Antares Pharma, Inc. | 2 | $47 |
| Teleflex LLC | 1 | $36 |
| AstraZeneca | 2 | $35 |
| Photocure Inc | 2 | $30 |
| BD | 1 | $30 |
| Clarus Therapeutics Inc. | 3 | $30 |
| Tolmar Pharmaceuticals, Inc. | 1 | $24 |
| 180 Medical, Inc. | 1 | $22 |
| Hollister Incorporated | 1 | $20 |
| Calyxo, Inc. | 1 | $19 |
| Telix Pharmaceuticals | 1 | $16 |
| Ambu Inc. | 1 | $14 |
How this compares
$16,288 in reported general payments places this provider in the 80th percentile of 179 urology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Foley
- Douglas TurnbullFoley$9K
- James McMurrayHuntsville$4.7M
- Vincent BivinsHomewood$1.3M
- Charles WhiteMobile$735K
- Thomas ChiBirmingham$628K
- Charles BuggHomewood$544K
- Charles PeytonBirmingham$543K
- Brian ChristineHomewood$372K
- Austin LutzHomewood$367K
- Joel FunkBirmingham$347K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.